NuVasive's Simplify Disc Receives FDA Approval for Two-Level Cervical Total Disc ReplacementPRNewsWire • 04/06/21
NuVasive and the International Spine Study Group Foundation Announce Expanded Long-Term Partnership with Initiation of Additional Clinical StudiesPRNewsWire • 03/16/21
NuVasive's (NUVA) CEO Chris Barry on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/26/21
Earnings Preview: NuVasive (NUVA) Q4 Earnings Expected to DeclineZacks Investment Research • 02/18/21
NuVasive Expands Clinical Professional Development Program with New East Coast Experience Center in New York Metropolitan AreaPRNewsWire • 02/08/21
NuVasive's X360 Procedural Approach Validated in Clinical Study Published in The Spine Journal Finding Single-Position Spine Surgery Improves Operative Efficiency While Reducing Complications and Length of Hospital StayPRNewsWire • 01/06/21
NuVasive to Participate in 39th Annual Virtual J.P. Morgan Healthcare ConferencePRNewsWire • 01/04/21
NuVasive to Participate in the Piper Sandler 32nd Annual Virtual Healthcare ConferencePRNewsWire • 11/23/20
NuVasive to Present at the Credit Suisse 29th Annual Virtual Healthcare ConferencePRNewsWire • 11/02/20
NuVasive, Inc. (NUVA) CEO Chris Barry on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 10/30/20